United States · biotech/health
United States · biotech/healthRevolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
Public · NASDAQ:RVMDFor profit
Why reach out now
What the record says about Revolution Medicines as a customer or partner.
- Has bought 2 companiesIt has done deals before: a sign it is open to partnerships.
Against its peers
Set against 435 biotech/health companies in United States. The ring marks the typical peer.
Across all 5.9M companies: larger than 92% of those with a size listed; older than 5% of those with a founding year; website ranked #536,637 in the world, about 62k visits a month.
About Revolution Medicines
Health CareLife ScienceMedical
Funding, as listed
What the source datasets report. We have not watched these rounds ourselves.
$1.5B
raised in total, currency not stated across 8 rounds
Last raised Mar 2023, 3 years ago
- Rounds
- 8
- Latest round
- Post ipo equity
- Investors
- 114 leading
Corporate family
Where it sits in its group, and the deals it has done.
Key facts
Who started it and how it trades.
- Founded by
- Alexis Borisy, David Pompliano, Mark A. Goldsmith, Martin D. Burke
Every detail we hold
Everything the source datasets list about Revolution Medicines, field by field. Contact details are held but never shown.
The company7 fields
- Name
- Revolution Medicines
- Type
- For profit
- Status
- Public · NASDAQ:RVMD
- Founded
- 2015
- Founders
- Alexis Borisy, David Pompliano, Mark A. Goldsmith, Martin D. Burke
- Industry
- biotech/health
- Categories
- Health Care, Life Science, Medical
Where3 fields
- City
- Redwood City
- Country
- United States
- Markets
- San Francisco Bay Area, Silicon Valley, West Coast, Western US
Size and reach3 fields
- Staff band
- 251-500
- Web traffic rank
- #536,637
- Monthly web visits
- 61,938
Show 11 more fieldsShow fewer fields
Funding, as listed8 fields
- Total
- 1,500,000,102 (currency not stated)
- Rounds
- 8
- Latest round
- Post ipo equity
- Latest round date
- Mar 2023
- Investors
- 11
- Lead investors
- 4
- Stock listing
- NASDAQ:RVMD
- Listing status
- public
Corporate family1 field
- Acquisitions made
- 2
About this record2 fields
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Revolution Medicines experienced a notable increase in its stock price by 11.0%. The company also received positive data in pancreatic cancer, which paved the way for a pivotal test of its drug. Additionally, Revolution Medicines earned a relative strength rating upgrade and joined the rank of stocks with RS ratings over 90. The stock price target was raised by H.C. Wainwright and JPMorgan due to impressive drug data and clinical updates.
Companies like Revolution Medicines
biotech/health in United States.
FreenomeSouth San Francisco · 501-1000 peoplefounded 1 years earlier
Relay TherapeuticsCambridge · 251-500 peoplefounded 1 years later
Denali TherapeuticsSan Francisco · 251-500 peoplefounded 2 years earlier
SpringWorks TherapeuticsStamford · 251-500 peoplefounded 2 years later
Arcus BiosciencesHayward · 101-250 peoplefounded the same yearBuild a lead list
435 biotech/health companies in United States, filtered by size, age and reach, ready to export with emails on Pro.